Venetoclax pharmacokinetics in subjects with end-stage renal disease undergoing hemodialysis

被引：0
|
作者：
Noorani, Behnam
Menon, Rajeev
Cen, Xin
Marsh, Kennan
Huang, Weize
Gupta, Shelly
Dobkowska, Edyta
Marbury, Thomas
Salem, Ahmed H.
机构：
[1] AbbVie Inc, N Chicago, IL USA
[2] AbbVie Inc, Chicago, IL USA
[3] Genentech Inc, San Francisco, CA USA
[4] Orlando Clin Res Ctr, Orlando, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19042
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysis
    Noorani, Behnam
    Menon, Rajeev M.
    Chen, Xin
    Marsh, Kennan C.
    Huang, Weize
    Gupta, Shelly
    Dobkowska, Edyta
    Marbury, Thomas
    Salem, Ahmed Hamed
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 748 - 758
  • [2] Safety, tolerability, and pharmacokinetics of edoxaban in end-stage renal disease subjects undergoing hemodialysis
    Parasrampuria, D.
    Matsushima, N.
    Chen, S.
    Wickremasingha, P. K.
    He, L.
    Dishy, V
    Brown, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 255 - 256
  • [3] THE PHARMACOKINETICS (PK) OF TOPIRAMATE (T) IN SUBJECTS WITH END-STAGE RENAL-DISEASE UNDERGOING HEMODIALYSIS
    GISCLON, LG
    CURTIN, CR
    SICA, DA
    GEHR, TWB
    SCHEIB, SS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 196 - 196
  • [4] Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
    Wang, Xiaoli
    Tirucherai, Giridhar
    Marbury, Thomas C.
    Wang, Jessie
    Chang, Ming
    Zhang, Donglu
    Song, Yan
    Pursley, Janice
    Boyd, Rebecca A.
    Frost, Charles
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (05): : 628 - 636
  • [5] Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
    Parasrampuria, Dolly A.
    Marbury, Thomas
    Matsushima, Nobuko
    Chen, Shuquan
    Wickremasingha, Prachi K.
    He, Ling
    Dishy, Victor
    Brown, Karen S.
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (04) : 719 - 727
  • [6] Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment
    Manitpisitkul, Prasarn
    Curtin, Christopher R.
    Shalayda, Kevin
    Wang, Shean-Sheng
    Ford, Lisa
    Heald, Donald L.
    EPILEPSY RESEARCH, 2014, 108 (05) : 891 - 901
  • [7] PHARMACOKINETICS AND PHARMACODYNAMICS OF EVOGLIPTIN IN END-STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS
    Kim, B.
    Yu, K.
    Lee, S.
    Oh, J.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S67 - S67
  • [8] THE PHARMACOKINETICS OF AMINOGUANIDINE IN END-STAGE RENAL-DISEASE PATIENTS ON HEMODIALYSIS
    FOOTE, EF
    LOOK, ZM
    GILES, P
    KEANE, WF
    HALSTENSON, CE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 420 - 425
  • [9] PHARMACOKINETICS OF ZIDOVUDINE IN END-STAGE RENAL-DISEASE - INFLUENCE OF HEMODIALYSIS
    PACHON, J
    CISNEROS, JM
    CASTILLO, JR
    GARCIAPESQUERA, F
    CANAS, E
    VICIANA, P
    AIDS, 1992, 6 (08) : 827 - 830
  • [10] PHARMACOKINETICS OF GABAPENTIN ENACARBIL IN SUBJECTS WITH RENAL IMPAIRMENT OF END-STAGE RENAL DISEASE
    Lal, Ritu
    Sukbuntherng, Juthamas
    Luo, Wendy
    Chen, Dan
    Blumenthal, Robin
    Ho, Judy
    Cundy, Kenneth C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1105 - 1105
12345